‘n-off’ phenomenon in Parkinson’s disease: Relationship between dopa and other large neutral amino acids in plasma

Neurology

Volumn 38, Issue 8, 1988, Pages 1245-1248

  Eriksson, Tomas ^a   Granérus, Ann Kathrine ^b   Linde, Anders ^a   Carlsson, Arvid ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA; LEVODOPA;

ADULT; AGED; AMINO ACID BLOOD LEVEL; CASE REPORT; HUMAN; MALE; ON OFF PHENOMENON; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN RESTRICTION;

AGED; AMINO ACIDS; DIHYDROXYPHENYLALANINE; DRUG INTERACTIONS; HUMAN; MALE; PARKINSON DISEASE; SUPPORT, NON-U.S. GOV'T;

EID: 0023730990     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.38.8.1245     Document Type: Article

References (22)

1. Barbeau A. The clinical physiology of side effects in long-term L-dopa therapy. In: McDowell FH, Barbeau A, eds. Advances in neurology, vol 5. New York Raven Press, 1974:347–365.
2. Granérus AK. Factors influencing the Occurrence of “on-off” symptom during long-term treatment with L-dopa. Acta Med Scand 1978;203:75–85.
3. Marsden CD. “On-off” phenomena in Parkinson’s disease. In: Rinne UK, Klingler M, Stamm G, eds. Parkinson’s disease: current progress, problems and management. Amsterdam: Elsevier/ North-Holland Biomedical Press, 1980:241–254.
4. Rinne UK. Problems associated with long-term levodopa treatment of Parkinson’s disease. Acta Neurol Scand 1983;68(suppl 15):19–26.
5. Lewitt PA, Chase TN. “On-off” effects: The new challenge in parkinsonism. Trends Neurosci 1983;6:1–4.
6. Woods AC, Glaubiger GA, Chase TN. Sustained-release levodopa. Lancet 1973;1:1391.
7. Fahn S. “On-off” phenomenon with levodopa therapy in parkinsonism. Neurology 1974;24:431–441.
8. Sweet RD, McDowell FH. Plasma dopa concentrations and the “on-off” effect after chronic treatment of Parkinson’s disease. Neurology 1974;24:953–956.
9. Yahr MD. Variations in the “on-off” effect. In: McDowell FH, Barbeau A, eds. Advances in neurology, vol 5. New York Raven Press, 1974:397–404.
10. Tolosa ES, Martin WE, Cohen HP, Jacobson RL. Patterns of clinical response and plasma dopa levels in Parkinson’s disease. Neurology 1975;25:177–183.
11. Pardridge W. Regulation of amino acid availability to the brain. In: Wurtman RJ, Wurtman JJ, eds. Nutrition and the brain. New York Raven Press, 1977:141–204.
12. Fernstrom JD. Role of precursor availability in control of mono-amine biosynthesie in brain. Physiol Rev 1983;63:484–546.
13. Eriksson T, Magnusson T, Carlsson A, Linde A, Granérus A-K. “On-off” phenomenon in Parkinson’s disease: correlation to the concentration of dopa in plasma. J Neural Transm 1984;59:229–240.
14. Sweet RD, McDowell FH. The “on-off” response to chronic L-dopa treatment in parkinsonism. In: McDowell FH, Barbeau A, eds. Advances in neurology, vol 5. New York: Raven Press, 1974:331–338.
15. Freed CR, Asmus PA. Brain tissue and plasma assay of L-dopa and alpha-methyldopa metabolites by high performance liquid chro-matography with electrochemical detection. J Neurochem 1979;32:163–168.
16. Mena I, Cotzias GC. Protein intake and treatment of Parkinson’s disease with levodopa. N Engl J Med 1975;292:181–184.
17. Nutt JG, Woodward WR, Hammerstad JP, Carter JH, Anderson JL. The “on-off” phenomenon in Parkinson’s disease: relation to levodopa absorption and transport. N Engl J Med 1984;310:483–488.
18. Carlsson A. Are “on-off” effects during chronic L-dopa treatment due to faulty feedback control of the nigrostriatal dopamine pathway? J Neural Transm 1983;(suppl 19):153–161.
19. Klawans HL, Goetz C, Nausieda PA, Weiner WJ. Levodopa-induced dopamine receptor hypersensitivity. Ann Neurol 1977;2:125–129.
20. Lee T, Seeman P, Rajput A, Farley IJ, Hornykiewicz O. Receptor basis for dopaminergic supersensitivity in Parkinson’s disease. Nature 1978;273:59–61.
21. Pycock C, Dawbarn D, O’Shaughnessy C. Behavioural and biochemical changes following chronic administration of L-dopa to rats. Eur J Pharmacol 1982;79:201–215.
22. Rinne UK, Koskinen V, Laaksonen H, Lönnberg P, Sonninen V. GABA receptor binding in the parkinsonian brain. Life Sci 1978;22:2225–2228.